肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

肿瘤发生和治疗过程中氨基酸分解代谢的免疫控制

Immune control by amino acid catabolism during tumorigenesis and therapy

原文发布日期:2019-01-29

DOI: 10.1038/s41568-019-0106-z

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

肿瘤发生和治疗过程中氨基酸分解代谢的免疫控制

Immune control by amino acid catabolism during tumorigenesis and therapy

原文发布日期:2019-01-29

DOI: 10.1038/s41568-019-0106-z

类型: Review Article

开放获取: 否

 

英文摘要:

Immune checkpoints arise from physiological changes during tumorigenesis that reprogramme inflammatory, immunological and metabolic processes in malignant lesions and local lymphoid tissues, which constitute the immunological tumour microenvironment (TME). Improving clinical responses to immune checkpoint blockade will require deeper understanding of factors that impact local immune balance in the TME. Elevated catabolism of the amino acids tryptophan (Trp) and arginine (Arg) is a common TME hallmark at clinical presentation of cancer. Cells catabolizing Trp and Arg suppress effector T cells and stabilize regulatory T cells to suppress immunity in chronic inflammatory diseases of clinical importance, including cancers. Processes that induce Trp and Arg catabolism in the TME remain incompletely defined. Indoleamine 2,3 dioxygenase (IDO) and arginase 1 (ARG1), which catabolize Trp and Arg, respectively, respond to inflammatory cues including interferons and transforming growth factor-β (TGFβ) cytokines. Dying cells generate inflammatory signals including DNA, which is sensed to stimulate the production of type I interferons via the stimulator of interferon genes (STING) adaptor. Thus, dying cells help establish local conditions that suppress antitumour immunity to promote tumorigenesis. Here, we review evidence that Trp and Arg catabolism contributes to inflammatory processes that promote tumorigenesis, impede immune responses to therapy and might promote neurological comorbidities associated with cancer.

 

摘要翻译: 

免疫检查点源于肿瘤发生过程中的生理变化,这些变化重编程了恶性病变区域及局部淋巴组织中的炎症、免疫及代谢过程,从而构成了免疫性肿瘤微环境(TME)。提高对免疫检查点阻断的临床反应,需要更深入地理解影响TME局部免疫平衡的因素。氨基酸色氨酸(Trp)和精氨酸(Arg)的分解代谢增强是癌症临床表现中TME的常见特征。分解代谢Trp和Arg的细胞通过抑制效应T细胞并稳定调节T细胞,在包括癌症在内的临床重要慢性炎症性疾病中抑制免疫反应。诱导TME中Trp和Arg分解代谢的过程仍未完全明确。分别催化Trp和Arg分解代谢的吲哚胺2,3-双加氧酶(IDO)和精氨酸酶1(ARG1)会对干扰素和转化生长因子-β(TGFβ)等炎症信号产生响应。垂死细胞产生的炎症信号(包括DNA)可通过干扰素基因刺激因子(STING)接头蛋白被感知,从而刺激I型干扰素的产生。因此,垂死细胞有助于建立抑制抗肿瘤免疫并促进肿瘤发生的局部条件。本文综述了证据表明Trp和Arg的分解代谢参与促进肿瘤发生、阻碍治疗免疫反应并可能加剧癌症相关神经共病的炎症过程。

 

原文链接:

Immune control by amino acid catabolism during tumorigenesis and therapy

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……